Atlas Trials

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

Clinical trial NCT01005199 · COMPLETED

Trial details

NCT number
NCT01005199
Sponsor
Swiss Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2009-11-01
Primary completion
2013-06-01
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.